Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAvidity Biosciences Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$1.53 | -$1.01 | -$1.28 |
| Q2 2026 | 1 | -$1.31 | -$1.31 | -$1.31 |
| Q3 2026 | 1 | -$1.36 | -$1.36 | -$1.36 |
| Q4 2026 | 1 | -$1.36 | -$1.36 | -$1.36 |
Avidity Biosciences Inc Earnings Date And Information
Avidity Biosciences Inc last posted its earnings results on Monday, November 10th, 2025. The company reported $-1.27 earnings per share for the quarter, missing analysts' consensus estimates of $-1.09 by $0.18. The company had revenue of 12.48 M for the quarter and had revenue of 10.90 M for the year. Avidity Biosciences Inc has generated $-3 earnings per share over the last year ($-2.89 diluted earnings per share) and currently has a price-to-earnings ratio of -18.28. Avidity Biosciences Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Avidity Biosciences Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/10/2025 | Q3 2025 | -$1.09 | -$1.27 | -0.18 | $1.94 M | $12.48 M |
| 08/07/2025 | Q2 2025 | -$0.95 | -$1.21 | -0.26 | $1.49 M | $3.85 M |
| 05/08/2025 | Q1 2025 | -$0.88 | -$0.90 | -0.02 | N/A | $1.57 M |
| 02/27/2025 | Q4 2024 | -$0.76 | -$0.80 | -0.04 | N/A | $2.97 M |
| 09/30/2024 | Q3 2024 | N/A | -$0.65 | N/A | $4.07 M | $2.34 M |
| 08/09/2024 | Q2 2024 | -$0.76 | -$0.66 | 0.1 | $2.63 M | $2.05 M |
| 05/09/2024 | Q1 2024 | -$0.81 | -$0.79 | 0.02 | N/A | $3.54 M |
| 02/28/2024 | Q4 2023 | -$0.54 | -$0.79 | -0.25 | N/A | $2.19 M |
| 11/08/2023 | Q3 2023 | -$0.76 | -$0.71 | 0.05 | N/A | $2.82 M |
| 08/08/2023 | Q2 2023 | -$0.84 | -$0.66 | 0.18 | N/A | $2.32 M |
| 05/09/2023 | Q1 2023 | -$0.90 | -$0.67 | 0.23 | N/A | $2.23 M |
| 02/28/2023 | Q4 2022 | -$0.84 | -$0.83 | 0.01 | N/A | $2.77 M |
| 11/08/2022 | Q3 2022 | -$0.97 | -$0.80 | 0.17 | N/A | $2.48 M |
| 08/09/2022 | Q2 2022 | -$0.74 | -$0.92 | -0.18 | N/A | $2.18 M |
| 05/10/2022 | Q1 2022 | -$0.94 | -$0.71 | 0.23 | N/A | $1.80 M |
| 03/01/2022 | Q4 2021 | -$0.73 | -$1.63 | -0.9 | N/A | $1.85 M |
| 11/09/2021 | Q3 2021 | -$0.63 | -$0.68 | -0.05 | N/A | $2.16 M |
| 08/09/2021 | Q2 2021 | -$0.77 | -$0.70 | 0.07 | N/A | $2.61 M |
| 05/12/2021 | Q1 2021 | -$0.52 | -$0.64 | -0.12 | N/A | $2.70 M |
| 03/15/2021 | Q4 2020 | -$0.34 | -$0.43 | -0.09 | N/A | $2.14 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Avidity Biosciences Inc Earnings: FAQ's
The conference call for Avidity Biosciences Inc's latest earnings report can be listened to online.
The conference call transcript for Avidity Biosciences Inc's latest earnings report can be read online.
Avidity Biosciences Inc (:RNA) has a recorded annual revenue of $10.90 M.
Avidity Biosciences Inc (:RNA) has a recorded net income of $-322,302,000.Avidity Biosciences Inc has generated $-2.89 earnings per share over the last four quarters.
Avidity Biosciences Inc (:RNA) has a price-to-earnings ratio of -18.28 and price/earnings-to-growth ratio is 1.05.